ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Jun 11, 2021 10:24 JST
Source:
NEC Corporation
Northgate Public Services to improve patient experience and outcomes with acquisition of Vantage Health
TOKYO & LONDON, Jun 11, 2021 - (JCN Newswire) - NEC Corporation (TSE: 6701) announced that Northgate Public Services (NPS), a wholly owned subsidiary of NEC, has acquired Vantage Health, which provides `Rego', an advanced digital solution to help healthcare providers reduce patient waiting times and cope with increased demand.
Rego reviews all referrals against local criteria and pathways and ensures patients are directed to the right care, the first time. Widely implemented across the U.K.'s National Health Service (NHS) to support thousands of general practitioners, dentists and opticians, Rego is proven to support effective outpatient transformation in line with the NHS' Long Term Plan and helping the organization as it looks towards recovery from the pandemic.
Tina Whitley, CEO of NPS, says: "Following the pandemic, healthcare is facing a huge challenge to keep up with the surge in demand for outpatient treatment. Effective solutions are needed to be able to manage resources, save money and secure the best outcomes for patients.
"Combining Vantage Health's ability to transform outpatient care with our expertise of managing successful health screening programmes like hearing and diabetic eye screening, means we can give healthcare providers the tools they need to quickly identify patients who need specialist services and then help them direct the patient to the right support service instantly."
David Ezra, co-founder of Vantage Health, says: "It's never been more important for the NHS and healthcare services to have efficient solutions that work. Joining forces with NPS is exciting. It brings together a shared vision for transforming the way healthcare is delivered to offer the best care for patients."
NPS already has a significant presence in this sector, following its acquisition of three EMIS Group plc businesses in 2019. This latest move further strengthens its growing preventative health offering.
NPS has helped to screen 10 million babies for the Newborn Hearing Screening Program in England and Northern Ireland, tested 500,000 patients with diabetes for retina damage and supports a number of medical registries such as the National Joint Registry (NJR), the largest orthopaedics registry in the world, and the international spinal registry platform, Spine Tango to help clinicians, regulators and industry deliver evidence-based treatments for patients.
Northgate Public Services (NPS) will become NEC Software Solutions UK from July 2021. The new name brings NPS under the global NEC brand, strengthening the company's position as a market leader in the development of cutting-edge software and services for the local government, police, health and housing sectors.
Source: NEC Corporation
Sectors: Cloud & Enterprise, MedTech
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Anime Tokyo Station TV Anime "SPYxFAMILY" Special Exhibition
Jul 22, 2025 11:00 JST
ShrimpTech JIRCAS and IMT Engineering Announce Strategic Collaboration to Advance Land-Based Aquaculture
Jul 22, 2025 09:00 JST
Peapack-Gladstone Financial Corporation Reports Second Quarter Financial Results
Jul 22, 2025 05:39 JST
Honda Koraidon First Showrun during Suzuka 8 Hours
Jul 18, 2025 11:06 JST
SJC2 optical submarine cable in operation
Jul 18, 2025 09:36 JST
MHI-AP Awarded Long-term Service Contract for the Garabogazkarbamid Fertilizer Plant in Turkmenistan
Jul 17, 2025 19:07 JST
Mitsubishi Motors Premieres the All-New Destinator in Indonesia
Jul 17, 2025 17:21 JST
Hitachi, global investment firm Brookfield, and global commodities trading firm Hartree Begin to Explore a Funding Scheme in the Environmentally-friendly Digital Infrastructure Sector
Jul 17, 2025 14:16 JST
"TOKIO Exciting Anime Workshop" Confirmed - Enjoy "Summer Festival at Anime Tokyo Station" This Summer Vacation
Jul 17, 2025 11:00 JST
Eisai Awarded "The 9th Bioindustry Award" for Drug Discovery Research for Anti- Amyloid B Monoclonal Antibody Lecanemab
Jul 16, 2025 14:50 JST
New Trains for Singapore's Sengkang-Punggol LRT Begin Commercial Operation
Jul 16, 2025 14:34 JST
AUG East Consortium and NEC to develop high-capacity submarine cable system across East Asia
Jul 16, 2025 14:00 JST
Anime Tokyo Station: Mobile Suit Gundam GQuuuuuuX -Beginning- Special Exhibition - New Designs Added for Admission Bonus Illustration Cards
Jul 16, 2025 11:00 JST
Fujitsu Data Intelligence PaaS enhances Mazda's data-utilization and decision-making
Jul 16, 2025 10:30 JST
Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection
Jul 16, 2025 10:20 JST
All Nippon Airways and Hitachi Unveil Japan's First Airline "Operations Brain" System, Enabling Rapid, Optimal Flight Schedule Revisions During Disruptions
Jul 15, 2025 12:00 JST
Fujitsu's AI-powered supply chain solution selected as transformative example of applied-AI technology by World Economic Forum
Jul 14, 2025 10:30 JST
"URECE" (Dotinurad) Launched in China as a treatment for Gout
Jul 14, 2025 10:20 JST
Mitsubishi Motors Added to FTSE4Good Index Series, FTSE Blossom Japan Index and FTSE Blossom Japan Sector Relative Index for Consecutive Years
Jul 11, 2025 16:28 JST
All-New MAZDA CX-5 Debuts in Europe
Jul 10, 2025 18:56 JST
More Latest Release >>
Related Release
SJC2 optical submarine cable in operation
7/18/2025 9:36:00 AM JST
AUG East Consortium and NEC to develop high-capacity submarine cable system across East Asia
7/16/2025 2:00:00 PM JST
Yachiyo Engineering and NEC launch adaptation finance study in Indonesia to calculate the adaptation value of disaster prevention measures
7/4/2025 1:25:00 PM JST
Executive Appointments in Connection with the Establishment of NESIC Holdings
6/23/2025 7:22:00 PM JST
NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment
6/18/2025 1:40:00 PM JST
Transgene and NEC Present Durable Disease-Free Survival and Sustained T Cell Responses at 24 months with Individualized Cancer Vaccine TG4050
6/2/2025 5:56:00 PM JST
IFS and NEC Strengthen their Strategic Partnership to Create New Value
5/30/2025 10:11:00 AM JST
NEC DGDF Headquarters relocates to Zurich to accelerate growth and enhance management globally
4/28/2025 4:03:00 PM JST
NEC invests in U.S.-based "Geodesic Alliance Fund" aiming to strengthen economic security business
4/24/2025 10:23:00 AM JST
NEC Face Recognition Ranks First in NIST Accuracy Testing
4/9/2025 11:09:00 AM JST
More Press release >>